The Relationship Between Sleep and Glucose Tolerance in Prediabetes: the Role of GLP-1 in Short Sleepers
NCT02229487 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51
Last updated 2017-10-10
Summary
Hypothesis
1. Prediabetes patients who have insufficient sleep will have worse glucose tolerance than those with normal sleep duration.
2. Prediabetes patients with short sleep will have a delayed or reduced GLP-1 response to a standardized meal
Conditions
Interventions
- OTHER
-
Oral glucose tolerance
Sponsors & Collaborators
- collaborator INDUSTRY
-
Ramathibodi Hospital
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-10-31
- Primary Completion
- 2017-03-31
- Completion
- 2017-03-31
Countries
- Thailand
Study Locations
More Related Trials
-
Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
NCT01234649 ·Status: COMPLETED ·Phase: PHASE3
-
The Importance of Ghrelin for Glucose Metabolism After Sleeve Gastrectomy
NCT05189353 ·Status: COMPLETED ·Phase: NA
-
Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patients
NCT06924697 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Sleep Apnea in Type 1 Diabetes
NCT01935765 ·Status: COMPLETED ·Phase: NA
-
Investigation of the Relationship Between Peripheral and Central Metabolic Changes Induced by GLP-1 Agonists
NCT06818292 ·Status: COMPLETED ·Phase: NA
-
Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness
NCT06487832 ·Status: RECRUITING ·Phase: NA
-
Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes
NCT05553093 ·Status: RECRUITING ·Phase: PHASE4
-
GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease
NCT06546384 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During Hypoglycemia
NCT00418288 ·Status: COMPLETED ·Phase: NA
-
Effect of GLP-1 Receptor Agonists on Trabecular Bone Score
NCT04964388 ·Status: TERMINATED ·Phase: PHASE2
-
Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes Mellitus
NCT05360147 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET
NCT01185119 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of 10-day Overnight Hypoxia Treatment on Whole Body Insulin Sensitivity (SLEEP HIGH Study)
NCT01872533 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus
NCT00923962 ·Status: COMPLETED ·Phase: NA
-
To Determine the Effect of GLP1 on Cognitive Function, Brain Glucose Metabolism and Neuroplasticity.
NCT03414333 ·Status: COMPLETED ·Phase: NA
-
The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes
NCT06976619 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM
NCT05093517 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Near Normalisation of BG Improves the Potentiating Effect of GLP-1
NCT00612625 ·Status: COMPLETED ·Phase: NA
-
GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations
NCT02082496 ·Status: COMPLETED ·Phase: PHASE2
-
Insulin Sensitivity and Metabolomics During Oral Administration of Glucose and Graded Intravenous Infusion
NCT03223129 ·Status: COMPLETED ·Phase: NA
-
Meal Frequency and Glycemic Control in Individuals With Type 1 Diabetes
NCT06934707 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Characterization of Metabolic and Brain Effects of Rising Glucagon During an Oral Glucose Challenge
NCT03061227 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Glucose Control, β Cell Function in Response to Short-term Insulin Pump Therapy in Type 2 Diabetes
NCT03509324 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of GLP-1 Receptor Agonist on Bone Metabolism in Patients With Diabetes Mellitus
NCT06182852 ·Status: NOT_YET_RECRUITING
-
Body Weight Regulation in Patients With Narcolepsy
NCT00283894 ·Status: COMPLETED